215 related articles for article (PubMed ID: 20640537)
1. Contrast-induced acute kidney injury: the at-risk patient and protective measures.
Brown JR; Thompson CA
Curr Cardiol Rep; 2010 Sep; 12(5):440-5. PubMed ID: 20640537
[TBL] [Abstract][Full Text] [Related]
2. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
[TBL] [Abstract][Full Text] [Related]
3. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced nephropathy in patients undergoing elective and urgent procedures.
Mautone A; Brown JR
J Interv Cardiol; 2010 Feb; 23(1):78-85. PubMed ID: 20465721
[TBL] [Abstract][Full Text] [Related]
5. In search of an algorithm to prevent acute kidney injury.
Dauerman HL
JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
[No Abstract] [Full Text] [Related]
6. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from the PRESERVE trial.
Partovi S; Trischman T; Kang PS
Br J Radiol; 2018 Jul; 91(1087):20180092. PubMed ID: 29770709
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis.
Zhang B; Liang L; Chen W; Liang C; Zhang S
BMJ Open; 2015 Mar; 5(3):e006989. PubMed ID: 25783425
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for contrast-induced acute kidney injury in high-risk patients given N-acetylcysteine prophylaxis.
Poh WY; Omar MS; Tan HP
Ann Saudi Med; 2018; 38(4):269-276. PubMed ID: 30078025
[TBL] [Abstract][Full Text] [Related]
10. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
Weisbord SD; Gallagher M; Kaufman J; Cass A; Parikh CR; Chertow GM; Shunk KA; McCullough PA; Fine MJ; Mor MK; Lew RA; Huang GD; Conner TA; Brophy MT; Lee J; Soliva S; Palevsky PM
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1618-31. PubMed ID: 23660180
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.
Martin-Moreno PL; Varo N; Martínez-Ansó E; Martin-Calvo N; Sayón-Orea C; Bilbao JI; Garcia-Fernandez N
Nephron; 2015; 131(1):51-8. PubMed ID: 26336919
[TBL] [Abstract][Full Text] [Related]
13. Protection from contrast-induced nephropathy: is the answer in?
Dean LS
Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
[No Abstract] [Full Text] [Related]
14. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
Hafiz AM; Jan MF; Mori N; Shaikh F; Wallach J; Bajwa T; Allaqaband S
Catheter Cardiovasc Interv; 2012 May; 79(6):929-37. PubMed ID: 21542114
[TBL] [Abstract][Full Text] [Related]
15. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
[TBL] [Abstract][Full Text] [Related]
16. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
17. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis.
Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H
Am J Kidney Dis; 2017 Jan; 69(1):69-77. PubMed ID: 27707552
[TBL] [Abstract][Full Text] [Related]
20. How to protect from contrast media-induced nephropathy?
Scheller B
Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
[No Abstract] [Full Text] [Related]
[Next] [New Search]